Rohit Singh

  • Researcher; PhD

Office no.: K06.063

 

Publications 2025

Singh R, Kyte JA (2025)
STEAP1: a promising target in prostate cancer therapy
Trends Cancer (in press)
DOI 10.1016/j.trecan.2025.05.007, PubMed 40527692

Publications 2024

Kim DE, Roh HS, Kim GH, Bhang DH, Um SH, Singh R, Baek KH (2024)
S6K1 deficiency in tumor stroma impairs lung metastasis of melanoma in mice
Biochem Biophys Res Commun, 696, 149469
DOI 10.1016/j.bbrc.2024.149469, PubMed 38194806

Singh R (2024)
Beyond the CAR T Cells: TIL Therapy for Solid Tumors
Immune Netw, 24 (2), e16
DOI 10.4110/in.2024.24.e16, PubMed 38725673

Singh R, Kim YH, Lee SJ, Eom HS, Choi BK (2024)
4-1BB immunotherapy: advances and hurdles
Exp Mol Med, 56 (1), 32-39
DOI 10.1038/s12276-023-01136-4, PubMed 38172595

Publications 2023

Cho E, Han S, Eom HS, Lee SJ, Han C, Singh R, Kim SH, Park BM, Kim BG, Kim YH, Kwon BS, Nam KT, Choi BK (2023)
Cross-Activation of Regulatory T Cells by Self Antigens Limits Self-Reactive and Activated CD8+ T Cell Responses
Int J Mol Sci, 24 (18)
DOI 10.3390/ijms241813672, PubMed 37761976

Cho E, Singh R, Han C, Kim SH, Kim KH, Park BM, Shin DH, Han S, Kim YH, Kwon BS, Nam KT, Choi BK (2023)
4-1BB-4-1BBL cis-interaction contributes to the survival of self-reactive CD8+ T cell
Cell Mol Immunol, 20 (9), 1077-1080
DOI 10.1038/s41423-023-01056-3, PubMed 37365325

Publications 2021

Singh R, Choi BK (2021)
A Transient Transfection-based Cell Adhesion Assay with 293T Cells
Bio Protoc, 11 (1), e3878
DOI 10.21769/BioProtoc.3878, PubMed 33732766

Yu EM, Cho E, Singh R, Kim SH, Han C, Han S, Lee DG, Kim YH, Kwon BS, Choi BK (2021)
IL7-Fc Enhances the Efficacy of Adoptive T Cell Therapy under Lymphopenic Conditions in a Murine Melanoma Model
Cells, 10 (8)
DOI 10.3390/cells10082018, PubMed 34440787

Publications 2020

Kim SH, Singh R, Han C, Cho E, Kim YI, Lee DG, Kim YH, Kim SS, Shin DH, You HJ, Lee HW, Kwon BS, Choi BK (2020)
Chronic activation of 4-1BB signaling induces granuloma development in tumor-draining lymph nodes that is detrimental to subsequent CD8+ T cell responses
Cell Mol Immunol, 18 (8), 1956-1968
DOI 10.1038/s41423-020-00533-3, PubMed 32868911

Publications 2019

Singh R, Choi BK (2019)
Siglec1-expressing subcapsular sinus macrophages provide soil for melanoma lymph node metastasis
Elife, 8
DOI 10.7554/eLife.48916, PubMed 31872800

Publications 2018

Choi BK, Hwang SH, Kim YI, Singh R, Kwon BS (2018)
The hyaluronic acid-rich node and duct system is a structure organized for innate immunity and mediates the local inflammation
Cytokine, 113, 74-82
DOI 10.1016/j.cyto.2018.06.011, PubMed 29907431

Han C, Sim SJ, Kim SH, Singh R, Hwang S, Kim YI, Park SH, Kim KH, Lee DG, Oh HS, Lee S, Kim YH, Choi BK, Kwon BS (2018)
Desensitized chimeric antigen receptor T cells selectively recognize target cells with enhanced antigen expression
Nat Commun, 9 (1), 468
DOI 10.1038/s41467-018-02912-x, PubMed 29391449

Publications 2014

Alqumber MA, Dar SA, Haque S, Wahid M, Singh R, Akhter N (2014)
No association of the TGF-β1 29T/C polymorphism with breast cancer risk in Caucasian and Asian populations: evidence from a meta-analysis involving 55,841 subjects
Asian Pac J Cancer Prev, 15 (20), 8725-34
DOI 10.7314/apjcp.2014.15.20.8725, PubMed 25374198

Publications 2013

Singh R, Kim WJ, Kim PH, Hong HJ (2013)
Combined blockade of HER2 and VEGF exerts greater growth inhibition of HER2-overexpressing gastric cancer xenografts than individual blockade
Exp Mol Med, 45 (11), e52
DOI 10.1038/emm.2013.111, PubMed 24176949

Publications 2012

Lee ES, Jeong MS, Singh R, Jung J, Yoon H, Min JK, Kim KH, Hong HJ (2012)
A chimeric antibody to L1 cell adhesion molecule shows therapeutic effect in an intrahepatic cholangiocarcinoma model
Exp Mol Med, 44 (4), 293-302
DOI 10.3858/emm.2012.44.4.027, PubMed 22248567